Basic design of shield blocks for a spallation neutron source under the high-intensity proton accelerator project

por Yoshida, K, Maekawa, F, Takada, H
Publicado 2003

Study on bulk shielding for a spallation neutron source facility in the high-intensity proton accelerator project

por Maekawa, F, Furusaka, M, Takada, H, Teshigawara, M, Watanabe, N
Publicado 2002

Treatment with YIGSR peptide ameliorates mouse tail lymphedema by 67 kDa laminin receptor (67LR)-dependent cell-cell adhesion

por Sakae, Y., Takada, H., Ichinose, S., Nakajima, M., Sakai, A., Ogawa, R.
Publicado 2023

A nontoxic tumour necrosis factor induced by streptococcal lipoteichoic acids.

por Usami, H., Yamamoto, A., Sugawara, Y., Hamada, S., Yamamoto, T., Kato, K., Kokeguchi, S., Takada, H., Kotani, S.
Publicado 1987

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients

por Bader-Meunier, B, Hachulla, P, Kuemmerle-Deschner, J, Gattorno, M, Patel, N, Preiss, R, Lheritier, K, Imagawa, T, Nishikomori, R, Takada, H, Heike, T, Hara, T, Yokota, S
Publicado 2011

Down-regulation of TGF-β receptors in human colorectal cancer: implications for cancer development

por Matsushita, M, Matsuzaki, K, Date, M, Watanabe, T, Shibano, K, Nakagawa, T, Yanagitani, S, Amoh, Y, Takemoto, H, Ogata, N, Yamamoto, C, Kubota, Y, Seki, T, Inokuchi, H, Nishizawa, M, Takada, H, Sawamura, T, Okamura, A
Publicado 1999